The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis

B. A. Clark, K. Kennedy, Susan Olson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: Fluorescence in situ hybridization aneuploidy screening promises immediate results. To evaluate aneuploidy screening in prenatal diagnosis, the prenatal records at Oregon were reviewed. Study design: Karyotype reports of 7240 amniocentesis samples referred for advanced maternal age were retrospectively reviewed for numeric and structural chromosome abnormalities. Results: The frequency of abnormal karyotypes was 2.5%; 1.4% were age-related trisomies and sex-chromosome aneuploids, and 1.1% were non-age-related abnormalities. The incidence of structural rearrangements was 0.9%, of which 70% were familial but not suspected on the basis of family history. Conclusions: Structural chromosome abnormalities were twice as common as previously reported, representing a significant unrecognized risk for subsequent pregnancies and other family members. Fluorescence in situ hybridization aneuploidy screening would not routinely detect structural chromosome abnormalities, which were twice as frequent as numeric aneuploidy at age 35 years. Routine use of fluorescence in situ hybridization for prenatal diagnosis should not be adopted without a prospective study of its accuracy, reliability, and impact on prenatal diagnosis.

Original languageEnglish (US)
Pages (from-to)812-816
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume168
Issue number3 I
StatePublished - 1993

Fingerprint

Trisomy
Maternal Age
Aneuploidy
Prenatal Diagnosis
Fluorescence In Situ Hybridization
Chromosome Aberrations
Abnormal Karyotype
Sex Chromosomes
Amniocentesis
Karyotype
Prospective Studies
Pregnancy
Incidence

Keywords

  • fluorescence in situ hybridization
  • prenatal diagnosis
  • structural chromosome abnormalities

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis. / Clark, B. A.; Kennedy, K.; Olson, Susan.

In: American Journal of Obstetrics and Gynecology, Vol. 168, No. 3 I, 1993, p. 812-816.

Research output: Contribution to journalArticle

@article{810006a572ba4f2eac064dc73a70dfd5,
title = "The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis",
abstract = "Objectives: Fluorescence in situ hybridization aneuploidy screening promises immediate results. To evaluate aneuploidy screening in prenatal diagnosis, the prenatal records at Oregon were reviewed. Study design: Karyotype reports of 7240 amniocentesis samples referred for advanced maternal age were retrospectively reviewed for numeric and structural chromosome abnormalities. Results: The frequency of abnormal karyotypes was 2.5{\%}; 1.4{\%} were age-related trisomies and sex-chromosome aneuploids, and 1.1{\%} were non-age-related abnormalities. The incidence of structural rearrangements was 0.9{\%}, of which 70{\%} were familial but not suspected on the basis of family history. Conclusions: Structural chromosome abnormalities were twice as common as previously reported, representing a significant unrecognized risk for subsequent pregnancies and other family members. Fluorescence in situ hybridization aneuploidy screening would not routinely detect structural chromosome abnormalities, which were twice as frequent as numeric aneuploidy at age 35 years. Routine use of fluorescence in situ hybridization for prenatal diagnosis should not be adopted without a prospective study of its accuracy, reliability, and impact on prenatal diagnosis.",
keywords = "fluorescence in situ hybridization, prenatal diagnosis, structural chromosome abnormalities",
author = "Clark, {B. A.} and K. Kennedy and Susan Olson",
year = "1993",
language = "English (US)",
volume = "168",
pages = "812--816",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3 I",

}

TY - JOUR

T1 - The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis

AU - Clark, B. A.

AU - Kennedy, K.

AU - Olson, Susan

PY - 1993

Y1 - 1993

N2 - Objectives: Fluorescence in situ hybridization aneuploidy screening promises immediate results. To evaluate aneuploidy screening in prenatal diagnosis, the prenatal records at Oregon were reviewed. Study design: Karyotype reports of 7240 amniocentesis samples referred for advanced maternal age were retrospectively reviewed for numeric and structural chromosome abnormalities. Results: The frequency of abnormal karyotypes was 2.5%; 1.4% were age-related trisomies and sex-chromosome aneuploids, and 1.1% were non-age-related abnormalities. The incidence of structural rearrangements was 0.9%, of which 70% were familial but not suspected on the basis of family history. Conclusions: Structural chromosome abnormalities were twice as common as previously reported, representing a significant unrecognized risk for subsequent pregnancies and other family members. Fluorescence in situ hybridization aneuploidy screening would not routinely detect structural chromosome abnormalities, which were twice as frequent as numeric aneuploidy at age 35 years. Routine use of fluorescence in situ hybridization for prenatal diagnosis should not be adopted without a prospective study of its accuracy, reliability, and impact on prenatal diagnosis.

AB - Objectives: Fluorescence in situ hybridization aneuploidy screening promises immediate results. To evaluate aneuploidy screening in prenatal diagnosis, the prenatal records at Oregon were reviewed. Study design: Karyotype reports of 7240 amniocentesis samples referred for advanced maternal age were retrospectively reviewed for numeric and structural chromosome abnormalities. Results: The frequency of abnormal karyotypes was 2.5%; 1.4% were age-related trisomies and sex-chromosome aneuploids, and 1.1% were non-age-related abnormalities. The incidence of structural rearrangements was 0.9%, of which 70% were familial but not suspected on the basis of family history. Conclusions: Structural chromosome abnormalities were twice as common as previously reported, representing a significant unrecognized risk for subsequent pregnancies and other family members. Fluorescence in situ hybridization aneuploidy screening would not routinely detect structural chromosome abnormalities, which were twice as frequent as numeric aneuploidy at age 35 years. Routine use of fluorescence in situ hybridization for prenatal diagnosis should not be adopted without a prospective study of its accuracy, reliability, and impact on prenatal diagnosis.

KW - fluorescence in situ hybridization

KW - prenatal diagnosis

KW - structural chromosome abnormalities

UR - http://www.scopus.com/inward/record.url?scp=0027474571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027474571&partnerID=8YFLogxK

M3 - Article

C2 - 8456886

AN - SCOPUS:0027474571

VL - 168

SP - 812

EP - 816

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3 I

ER -